scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1018122093 |
P356 | DOI | 10.1038/SREP20855 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/srep20855 |
P932 | PMC publication ID | 4749988 |
P698 | PubMed publication ID | 26865350 |
P5875 | ResearchGate publication ID | 294284091 |
P50 | author | Kaoru Sakatani | Q57016404 |
P2093 | author name string | Hiroyuki Arai | |
Kazuo Tsubota | |||
Tetsuya Kawakita | |||
Miki Uchino | |||
Ikuko Toda | |||
Kazumi Fukagawa | |||
Mari Tanaka | |||
Kenichi Yoshino | |||
Seiichiro Hata | |||
Seika Shimazaki | |||
Takashi Okano | |||
P2860 | cites work | Visual fatigue and occupational stress in VDT operators | Q23917921 |
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies | Q24646616 | ||
Psychological factors and visual fatigue in working with video display terminals | Q24670194 | ||
Diagnostic tests in the Sicca syndrome | Q70112003 | ||
Practical double vital staining for ocular surface evaluation | Q72089084 | ||
Ocular fatigue is the major symptom of dry eye | Q72906255 | ||
Sjögren's syndrome | Q75219081 | ||
Tear dynamics and dry eye | Q77429291 | ||
Anti-inflammatory therapy of dry eye | Q79317939 | ||
Protective Effect ofd-β-Hydroxybutyrate on Corneal Epithelia in Dry Eye Conditions through Suppression of Apoptosis | Q33194215 | ||
Autologous serum eye drops for the treatment of dry eye diseases | Q34013889 | ||
Sodium hyaluronate eyedrops in the treatment of dry eyes | Q34368785 | ||
Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years | Q34443357 | ||
Epidemiology of dry eye syndrome. | Q35076489 | ||
Treatment of dry eye by autologous serum application in Sjögren's syndrome | Q35309629 | ||
A review of the Schirmer test for tear production | Q35385802 | ||
Regulatory pathways in lacrimal gland epithelium | Q35624258 | ||
D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease | Q35919815 | ||
D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease | Q36976707 | ||
Advances in understanding and managing dry eye disease | Q37206550 | ||
Corneal injuries | Q39631416 | ||
Tear physiology and dry eyes | Q39709731 | ||
Physiological roles of ketone bodies as substrates and signals in mammalian tissues | Q40280929 | ||
Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group | Q40765221 | ||
Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. | Q40948258 | ||
Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. | Q42684410 | ||
Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia | Q44040992 | ||
Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease | Q44401535 | ||
D-beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board | Q46568367 | ||
Autologous serum eye drops for dry eye after LASIK. | Q46920180 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
multicenter clinical trial | Q6934595 | ||
P304 | page(s) | 20855 | |
P577 | publication date | 2016-02-11 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease | |
P478 | volume | 6 |
Q41189285 | Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma | cites work | P2860 |
Search more.